308 related articles for article (PubMed ID: 12068130)
21. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
Tahara K; Yamamoto K; Tamura Y; Yoshida S
Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor.
Schwarz-Lauer L; Chazenbalk GD; Mclachlan SM; Ochi Y; Nagayama Y; Rapoport B
Thyroid; 2002 Feb; 12(2):115-20. PubMed ID: 11916280
[TBL] [Abstract][Full Text] [Related]
23. Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves' disease.
Marazuela M; Steegman JL
Bone Marrow Transplant; 2000 Dec; 26(11):1217-20. PubMed ID: 11149734
[TBL] [Abstract][Full Text] [Related]
24. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
25. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
27. Hyperthyroid Graves' disease and primary hypothyroidism caused by TSH receptor antibodies in monozygotic twins: case reports.
Tani J; Yoshida K; Fukazawa H; Kiso Y; Sayama N; Mori K; Aizawa Y; Hori H; Nakasato N; Abe K
Endocr J; 1998 Feb; 45(1):117-21. PubMed ID: 9625455
[TBL] [Abstract][Full Text] [Related]
28. [Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach].
Akamizu T; Kosugi S; Kohn LD; Mori T
Nihon Rinsho; 1994 Apr; 52(4):1024-30. PubMed ID: 7515117
[TBL] [Abstract][Full Text] [Related]
29. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
30. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
31. Assays for thyroid-stimulating hormone receptor antibodies employing different ligands and ligand partners may have similar sensitivity and specificity but are not interchangeable.
Pedersen IB; Handberg A; Knudsen N; Heickendorff L; Laurberg P
Thyroid; 2010 Feb; 20(2):127-33. PubMed ID: 20151820
[TBL] [Abstract][Full Text] [Related]
32. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
Meller J; Jauho A; Hüfner M; Gratz S; Becker W
Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
[TBL] [Abstract][Full Text] [Related]
33. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies.
McKenzie JM; Zakarija M
Thyroid; 1992; 2(2):155-9. PubMed ID: 1356056
[TBL] [Abstract][Full Text] [Related]
34. Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity.
Costagliola S; Bonomi M; Morgenthaler NG; Van Durme J; Panneels V; Refetoff S; Vassart G
Mol Endocrinol; 2004 Dec; 18(12):3020-34. PubMed ID: 15319453
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of thyroid-stimulating and -blocking antibodies to the thyrotropin receptor in a murine model of Graves' disease.
Muehlberg T; Gilbert JA; Rao PV; McGregor AM; Banga JP
Endocrinology; 2004 Apr; 145(4):1539-45. PubMed ID: 14764633
[TBL] [Abstract][Full Text] [Related]
36. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
Minich WB; Loos U
Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
[TBL] [Abstract][Full Text] [Related]
37. [Thyroid autoantibodies].
Le NH; Ballieux BE; Corssmit EP
Ned Tijdschr Geneeskd; 2015; 159():A8802. PubMed ID: 26104003
[TBL] [Abstract][Full Text] [Related]
38. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
[TBL] [Abstract][Full Text] [Related]
39. Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites.
Morgenthaler NG; Ho SC; Minich WB
J Clin Endocrinol Metab; 2007 Mar; 92(3):1058-65. PubMed ID: 17179194
[TBL] [Abstract][Full Text] [Related]
40. Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases.
Takasu N; Yamada T; Sato A; Nakagawa M; Komiya I; Nagasawa Y; Asawa T
Clin Endocrinol (Oxf); 1990 Dec; 33(6):687-98. PubMed ID: 1982861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
